1. Home
  2. UTHR vs USFD Comparison

UTHR vs USFD Comparison

Compare UTHR & USFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • USFD
  • Stock Information
  • Founded
  • UTHR 1996
  • USFD 2007
  • Country
  • UTHR United States
  • USFD United States
  • Employees
  • UTHR N/A
  • USFD N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • USFD Food Distributors
  • Sector
  • UTHR Health Care
  • USFD Consumer Discretionary
  • Exchange
  • UTHR Nasdaq
  • USFD Nasdaq
  • Market Cap
  • UTHR 20.7B
  • USFD 16.9B
  • IPO Year
  • UTHR 1999
  • USFD 2016
  • Fundamental
  • Price
  • UTHR $437.62
  • USFD $73.79
  • Analyst Decision
  • UTHR Buy
  • USFD Strong Buy
  • Analyst Count
  • UTHR 16
  • USFD 11
  • Target Price
  • UTHR $472.94
  • USFD $88.82
  • AVG Volume (30 Days)
  • UTHR 629.5K
  • USFD 1.6M
  • Earning Date
  • UTHR 10-29-2025
  • USFD 11-06-2025
  • Dividend Yield
  • UTHR N/A
  • USFD N/A
  • EPS Growth
  • UTHR 16.08
  • USFD 10.81
  • EPS
  • UTHR 26.38
  • USFD 2.33
  • Revenue
  • UTHR $3,128,400,000.00
  • USFD $38,652,000,000.00
  • Revenue This Year
  • UTHR $13.82
  • USFD $6.58
  • Revenue Next Year
  • UTHR $5.71
  • USFD $6.12
  • P/E Ratio
  • UTHR $16.63
  • USFD $31.62
  • Revenue Growth
  • UTHR 13.50
  • USFD 5.32
  • 52 Week Low
  • UTHR $266.98
  • USFD $57.36
  • 52 Week High
  • UTHR $479.50
  • USFD $85.11
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 54.98
  • USFD 40.52
  • Support Level
  • UTHR $409.15
  • USFD $72.20
  • Resistance Level
  • UTHR $479.50
  • USFD $74.08
  • Average True Range (ATR)
  • UTHR 13.84
  • USFD 1.41
  • MACD
  • UTHR -0.64
  • USFD -0.19
  • Stochastic Oscillator
  • UTHR 40.46
  • USFD 26.55

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About USFD US Foods Holding Corp.

US Foods Holding Corp is the U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, and education, government facilities, and grocers. It has nearly 250,000 restaurants and foodservice operators with more than 70 locations that provide customers with food offering and a comprehensive suite of e-commerce, technology, and business solutions. The company operates in one business segment in which it markets, sells and distributes fresh, frozen and dry food and non-food products to foodservice customers throughout the U.S.

Share on Social Networks: